BUJARD HERMANN has a total of 15 patent applications. Its first patent ever was published in 1995. It filed its patents most often in Canada, EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are VAXINNATE CORP, BIOLOGICAL MIMETICS INC and SALLBERG MATTI.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 3 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | United States | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Australia | 1 | |
#6 | Brazil | 1 | |
#7 | Indonesia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Agriculture |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Climate change adaptation technologies | |
#5 | Microorganisms | |
#6 | Animal care |
# | Name | Total Patents |
---|---|---|
#1 | Bujard Hermann | 13 |
#2 | Lutz Rolf | 6 |
#3 | Kauth Christian | 6 |
#4 | Epp Christian | 6 |
#5 | Woehlbier Ute | 5 |
#6 | Tolle Ralf | 3 |
#7 | Pan Weiqing | 3 |
#8 | Gossen Manfred | 2 |
#9 | Hillen Wolfgang | 1 |
#10 | Woehlbier Ute Dr | 1 |
Publication | Filing date | Title |
---|---|---|
EP2141177A1 | MSP-1 protein preparations from Plasmodium | |
EP0929677A2 | Recombinant method for preparing a complete malaria antigen gp190/msp1 |